نتائج البحث - Thomas Graillon

  • يعرض 1 - 9 نتائج من 9
تنقيح النتائج
  1. 1
    Skull Base Chordomas and Chondrosarcomas

    Skull Base Chordomas and Chondrosarcomas حسب Natalia Kremenevski, Sven-Martin Schlaffer, Roland Coras, Thomas M. Kinfe, Thomas Graillon, Michael Buchfelder

    منشور في 2020
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    Octreotide therapy in meningiomas: in vitro study, clinical correlation, and literature review

    Octreotide therapy in meningiomas: in vitro study, clinical correlation, and literature review حسب Thomas Graillon, David Romano, Céline Defilles, Alexandru Saveanu, Amira Mohamed, Dominique Figarella‐Branger, Pierre‐Hugues Roche, S. Fuentès, Olivier Chinot, Henry Dufour, Anne Barlier

    منشور في 2016
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    Real-life clinical impact of a five-tiered classification of pituitary tumors

    Real-life clinical impact of a five-tiered classification of pituitary tumors حسب Nicolas Sahakian, Romain Appay, Noémie Resseguier, Thomas Graillon, Cécilia Piazzola, Cécilia Laure, Dominique Figarella‐Branger, Jean Régis, Frédéric Castinetti, Thierry Brue, Henry Dufour, Thomas Cuny

    منشور في 2022
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    Recurrence of glioblastoma after radio-chemotherapy is associated with an angiogenic switch to the CXCL12-CXCR4 pathway

    Recurrence of glioblastoma after radio-chemotherapy is associated with an angiogenic switch to the CXCL12-CXCR4 pathway حسب Émeline Tabouret, Aurélie Tchoghandjian, Emilie Denicolaï, Christine Delfino, Philippe Métellus, Thomas Graillon, Céline Boucard, Isabelle Nanni, Laëtitia Padovani, L’Houcine Ouafik, Dominique Figarella‐Branger, Olivier Chinot

    منشور في 2015
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  5. 5
    De novo and secondary anaplastic meningiomas: a study of clinical and histomolecular prognostic factors

    De novo and secondary anaplastic meningiomas: a study of clinical and histomolecular prognostic factors حسب Matthieu Peyre, Guillaume Gauchotte, Marine Giry, Sébastien Froehlich, Johan Pallud, Thomas Graillon, Franck Bielle, Dominique Cazals–Hatem, Pascale Varlet, Dominique Figarella‐Branger, Hugues Loiseau, Michel Kalamarides

    منشور في 2017
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  6. 6
    Everolimus and Octreotide for Patients with Recurrent Meningioma: Results from the Phase II CEVOREM Trial

    Everolimus and Octreotide for Patients with Recurrent Meningioma: Results from the Phase II CEVOREM Trial حسب Thomas Graillon, Marc Sanson, Chantal Campello, Ahmed Idbaïh, Matthieu Peyre, Hadrien Peyrière, Noémie Basset, Didier Autran, Catherine Roche‐Lestienne, Michel Kalamaridès, Pièrre-Hugues Roche, S. Fuentès, Émeline Tabouret, Maryline Barrié, Anita Cohen, Stéphane Honoré, Mohamed Boucékine, Karine Baumstarck, Dominique Figarella‐Branger, Anne Barlier, Henry Dufour, Olivier Chinot

    منشور في 2020
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  7. 7
    Plasmatic MMP9 released from tumor-infiltrating neutrophils is predictive for bevacizumab efficacy in glioblastoma patients: an AVAglio ancillary study

    Plasmatic MMP9 released from tumor-infiltrating neutrophils is predictive for bevacizumab efficacy in glioblastoma patients: an AVAglio ancillary study حسب Carine Jiguet‐Jiglaire, Sébastien Boissonneau, Emilie Denicolaï, Victoria Hein, Romain Lasseur, Josep Garcia, Sylvie Romain, Romain Appay, Thomas Graillon, Warren Mason, Alain Carpentier, Alba A. Brandes, L’Houcine Ouafik, Wolfgang Wick, Ania Baaziz, Julien P. Gigan, Rafael J. Argüello, Dominique Figarella‐Branger, Olivier Chinot, Émeline Tabouret

    منشور في 2022
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  8. 8
    Somatostatin Receptor–Targeted Radiopeptide Therapy in Treatment-Refractory Meningioma: Individual Patient Data Meta-analysis

    Somatostatin Receptor–Targeted Radiopeptide Therapy in Treatment-Refractory Meningioma: Individual Patient Data Meta-analysis حسب Christian Mirian, Anne Katrine Duun‐Henriksen, Andrea Daniela Maier, Maria Møller Pedersen, Lasse Rehné Jensen, Asma Bashir, Thomas Graillon, Maya Hrachova, Daniela A. Bota, Martijn van Essen, Petar Spanjol, Christian Kreis, Ian Law, Helle Broholm, Lars Poulsgaard, Kåre Fugleholm, Morten Ziebell, Tina Nørgaard Munch, Martin A. Walter, Tiit Mathiesen

    منشور في 2020
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  9. 9
    Activity of PD-1 blockade with nivolumab among patients with recurrent atypical/anaplastic meningioma: phase II trial results

    Activity of PD-1 blockade with nivolumab among patients with recurrent atypical/anaplastic meningioma: phase II trial results حسب Wenya Linda Bi, Lakshmi Nayak, David M. Meredith, Joseph Driver, Ziming Du, Samantha E. Hoffman, Yvonne Li, Eudocia Q. Lee, Rameen Beroukhim, Mikael L. Rinne, Ricardo McFaline-Figueroa, Ugonma Chukwueke, Christine McCluskey, Sarah Gaffey, Andrew D. Cherniack, Jennifer Stefanik, Lisa Doherty, Christina Taubert, Meghan Cifrino, D. C. LaFrankie, Thomas Graillon, Patrick Y. Wen, Keith L. Ligon, Ossama Al‐Mefty, Raymond Y. Huang, Alona Muzikansky, E. Antonio Chiocca, Sandro Santagata, Ian F. Dunn, David A. Reardon

    منشور في 2021
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: